Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Not applicable Interventional Results available

Durolane Versus Phosphate Buffered Saline (PBS) in Knee Osteoarthritis

ClinicalTrials.gov ID: NCT01753830

Public ClinicalTrials.gov record NCT01753830. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 11:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi Center, Randomized, Double Blind, Saline Controlled Study of a Single Injection of Durolane® Versus a Single Injection of Phosphate Buffered Saline (PBS) to Treat Pain Associated With Osteoarthritis of the Knee

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to determine whether a single intra-articular injection of Durolane 4.5 mL is superior to a single injection of PBS 4.5 mL for the relief of joint pain in patients with osteoarthritis of the knee.

Study identification

NCT ID
NCT01753830
Recruitment status
Terminated
Study type
Interventional
Phase
Not applicable
Lead sponsor
Galderma R&D
Industry
Enrollment
75 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2012 (Type not available)
Primary completion
Feb 2014 (Actual)
Completion
Feb 2014 (Actual)
Last update posted
Aug 26, 2022

2012 – 2014

United States locations

U.S. sites
25
U.S. states
17
U.S. cities
25
Facility City State ZIP Site status
Not listed Anniston Alabama — —
Not listed Mobile Alabama — —
Not listed Phoenix Arizona — —
Not listed Tucson Arizona — —
Not listed Hot Springs Arkansas — —
Not listed Beverly Hills California — —
Not listed El Cajon California — —
Not listed Boulder Colorado — —
Not listed Danbury Connecticut — —
Not listed Trumbull Connecticut — —
Not listed Lauderdale Lakes Florida — —
Not listed Pinellas Park Florida — —
Not listed South Miami Florida — —
Not listed Boise Idaho — —
Not listed Meridian Idaho — —
Not listed Evansville Indiana — —
Not listed New Orleans Louisiana — —
Not listed Wheaton Maryland — —
Not listed Kalamazoo Michigan — —
Not listed Springfield Missouri — —
Not listed Oklahoma City Oklahoma — —
Not listed Duncansville Pennsylvania — —
Not listed Wyomissing Pennsylvania — —
Not listed Charleston South Carolina — —
Not listed Norfolk Virginia — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01753830, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 26, 2022 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01753830 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →